CTCarolina Tarantino

Carolina Tarantino

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Carolina Tarantino has a total of 114 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Bioelectronic Recordings of Cardiomyocytes with Accumulation Mode Electrolyte Gated Organic Field Effect Transistors

    by Adrica Kyndiah, Francesca Leonardi, Carolina Tarantino, Tobias Cramer, Ruben Millan-Solsona, Elena Garreta, Núria Montserrat, Marta Mas-Torrent, Gabriel Gomila


  • Top Cited Papers

    Fine tuning the extracellular environment accelerates the derivation of kidney organoids from human pluripotent stem cells

    by Elena Garreta, Patricia Prado, Carolina Tarantino, Roger Oria, Lucia Fanlo, Elisa Martí, Dobryna Zalvidea, Xavier Trepat, Pere Roca-Cusachs, Aleix Gavaldà-Navarro, et al.

    The generation of organoids is one of the biggest scientific advances in regenerative medicine. Here, by lengthening the time that human pluripotent stem cells (hPSCs) were exposed to a three-dimensional microenvironment, and by applying defined renal inductive signals, we generated kidney organoids that transcriptomically matched second-trimester human fetal kidneys. We validated these results using ex vivo and in vitro assays that model renal development. Furthermore, we developed a transplantation method that utilizes the chick chorioallantoic membrane. This approach created a soft in vivo microenvironment that promoted the growth and differentiation of implanted kidney organoids, as well as providing a vascular component. The stiffness of the in ovo chorioallantoic membrane microenvironment was recapitulated in vitro by fabricating compliant hydrogels. These biomaterials promoted the efficient generation of renal vesicles and nephron structures, demonstrating that a soft environment accelerates the differentiation of hPSC-derived kidney organoids.


  • Open Access

    Eph-ephrin signaling modulated by polymerization and condensation of receptors

    by Samuel Ojosnegros, Francesco Cutrale, Daniel Rodríguez, Jason J. Otterstrom, Chi Li Chiu, Verónica Hortigüela, Carolina Tarantino, Anna Seriola, Stephen Mieruszynski, Elena Martínez, et al.

    Eph receptor signaling plays key roles in vertebrate tissue boundary formation, axonal pathfinding, and stem cell regeneration by steering cells to positions defined by its ligand ephrin. Some of the key events in Eph-ephrin signaling are understood: ephrin binding triggers the clustering of the Eph receptor, fostering transphosphorylation and signal transduction into the cell. However, a quantitative and mechanistic understanding of how the signal is processed by the recipient cell into precise and proportional responses is largely lacking. Studying Eph activation kinetics requires spatiotemporal data on the number and distribution of receptor oligomers, which is beyond the quantitative power offered by prevalent imaging methods. Here we describe an enhanced fluorescence fluctuation imaging analysis, which employs statistical resampling to measure the Eph receptor aggregation distribution within each pixel of an image. By performing this analysis over time courses extending tens of minutes, the information-rich 4D space (x, y, oligomerization, time) results were coupled to straightforward biophysical models of protein aggregation. This analysis reveals that Eph clustering can be explained by the combined contribution of polymerization of receptors into clusters, followed by their condensation into far larger aggregates. The modeling reveals that these two competing oligomerization mechanisms play distinct roles: polymerization mediates the activation of the receptor by assembling monomers into 6- to 8-mer oligomers; condensation of the preassembled oligomers into large clusters containing hundreds of monomers dampens the signaling. We propose that the polymerization–condensation dynamics creates mechanistic explanation for how cells properly respond to variable ligand concentrations and gradients.


  • Open Access

    Tissue engineering by decellularization and 3D bioprinting

    by Elena Garreta, Roger Oria, Carolina Tarantino, Mateu Pla-Roca, Patricia Prado, Francisco Fernández-Avilés, Josep Maria Campistol, Josep Samitier, Nuria Montserrat


  • Open Access

    Myocardial commitment from human pluripotent stem cells: Rapid production of human heart grafts

    by Elena Garreta, Lorena de Oñate, M. Eugenia Fernández-Santos, Roger Oria, Carolina Tarantino, Andreu M. Climent, Andrés Marco, Mireia Samitier, Elena Martínez, Maria Valls-Margarit, et al.


  • Open Access

    Research on Skeletal Muscle Diseases Using Pluripotent Stem Cells

    by Lorena de Oñate, Elena Garreta, Carolina Tarantino, Elena Martínez, Encarnación Capilla, Isabel Navarro, Joaquín Gutiérrez, Josep Samitier, Josep Maria Campistol, Pura Muñoz-Cánovas, et al.


  • Open Access

    Modelling Fanconi anemia pathogenesis and therapeutics using integration-free patient-derived iPSCs

    by Guang-Hui Liu, Keiichiro Suzuki, Mo Li, Jing Qu, Nuria Montserrat, Carolina Tarantino, Ying Gu, Fei Yi, Xiuling Xu, Weiqi Zhang, et al.

    Fanconi anaemia (FA) is a recessive disorder characterized by genomic instability, congenital abnormalities, cancer predisposition and bone marrow (BM) failure. However, the pathogenesis of FA is not fully understood partly due to the limitations of current disease models. Here, we derive integration free-induced pluripotent stem cells (iPSCs) from an FA patient without genetic complementation and report in situ gene correction in FA–iPSCs as well as the generation of isogenic FANCA-deficient human embryonic stem cell (ESC) lines. FA cellular phenotypes are recapitulated in iPSCs/ESCs and their adult stem/progenitor cell derivatives. By using isogenic pathogenic mutation-free controls as well as cellular and genomic tools, our model serves to facilitate the discovery of novel disease features. We validate our model as a drug-screening platform by identifying several compounds that improve hematopoietic differentiation of FA–iPSCs. These compounds are also able to rescue the hematopoietic phenotype of FA patient BM cells.


  • Open Access

    A regulatory loop involving Dies1 and miR‐125a controls BMP4 signaling in mouse embryonic stem cells

    by Silvia Parisi, Marica Battista, Anna Musto, Angelica Navarra, Carolina Tarantino, Tommaso Russo

    Bone morphogenetic protein 4 (BMP4) plays an important role in maintaining embryonic stem cells (ESCs) in the undifferentiated state and in the regulation of lineage commitment. We recently identified a transmembrane protein, named Dies1, the suppression of which by RNA interference blocks mouse ESC differentiation by interfering with the BMP4 signaling. We asked whether modulation of Dies1 levels could be a physiological mechanism to regulate ESC pluripotency and/or differentiation. We demonstrated that miR‐125a targets Dies1 and regulates its expression in ESCs. The overexpression of miR‐125a impairs differentiation, and this effect is specifically mediated by Dies1 down‐regulation and accompanied by a decrease of BMP4 signaling. We also found that Dies1 is associated with BMP4 receptor complex and that BMP4 activates the transcription of miR‐125a gene. Therefore, a feedback loop exists that sets ESC sensitivity to BMP4. The analysis of this regulatory mechanism revealed that miR‐125a overexpression and the consequent inhibition of the BMP4 signaling arrest the cells in the epiblast stem cell (epiSC) status, due to the concomitant activation of the Nodal/Activin pathway.—Parisi, S., Battista, M., Musto, A., Navarra, A., Tarantino, C., Russo, T. A regulatory loop involving Dies1 and miR‐125a controls BMP4 signaling in mouse embryonic stem cells. FASEB J. 26, 3957–3968 (2012). www.fasebj.org


  • Serum withdrawal after embryoid body formation does not impair cardiomyocyte development from mouse embryonic stem cells

    by Gianluca Testa, Carolina Tarantino, Silvia Parisi, Gianluigi Galizia, Fabiana Passaro, David Della-Morte, Pasquale Abete, Franco Rengo, Francesco Salvatore, Lucio Pastore


  • A Flexible Method to Study Neuronal Differentiation of Mouse Embryonic Stem Cells

    by Silvia Parisi, Carolina Tarantino, Gaetana Paolella, Tommaso Russo

    Embryonic Stem Cells (ESCs) represent an invaluable tool for the study of early mammalian development, for regenerative medicine and for drug discovery. To fulfill these promises, efficient and easy protocols to differentiate ESCs have to be developed. Most of these protocols results in low efficiency of neural induction and/or requires extended in vitro culture. Here we describe in detail an easy and efficient method to differentiate ESCs into neurons, that can be used to identify molecules required for proper neuronal differentiation. Moreover, we present a modification of this method that allows to clearly evaluate the ability of some molecules to favor neuron formation in vitro. These methods can represent an efficient platform for studying the molecular mechanisms underlying early events of neural induction and differentiation in ESCs, as well as for testing molecule efficacy in the pharmaceutical testing.